Read + Share
Hummel J, Machann J, Dannecker C, Kullmann S, et al. Eight weeks of empagliflozin does not affect pancreatic fat content and insulin
secretion in people with prediabetes. Diabetes Obes Metab 2022;24:1661-1666.
PMID: 35475570
|
 |
|
Hummel J, Machann J, Dannecker C, Kullmann S, et al. Eight weeks of empagliflozin does not affect pancreatic fat content and insulin
secretion in people with prediabetes. Diabetes Obes Metab 2022;24:1661-1666.
PMID: 35475570
|
|
|
|